Medigen Vaccine Biologics Corporation
From Wikipedia, the free encyclopedia
.jpg) | |
Native name | 高端疫苗生物製劑 |
|---|---|
| Founded | October 2012 |
| Headquarters | Neihu, Taipei, Taiwan |
| Parent | Medigen Biotechnology Corporation |
| Website | Official website |
The Medigen Vaccine Biologics Corporation (MVC; traditional Chinese: 高端疫苗生物製劑; simplified Chinese: 高端疫苗生物制剂; pinyin: Gāoduān Yìmiáo Shēngwù Zhìjì) is a pharmaceutical company headquartered in Neihu, Taipei, Taiwan.
The company was founded in October 2012.[1] During the COVID-19 pandemic in Taiwan, the company produces the MVC COVID-19 vaccine to fight the virus.[2]
On 18 March 2026, Vietnam's Ministry of Health has approved the rollout of the Medigen enterovirus vaccine in Vietnam, which is the company's first overseas rollout.[3][4]
Manufacturing plant
The company has a manufacturing plant in Hsinchu Biomedical Science Park, Zhubei City, Hsinchu County.[5]
